Medication selected from your labs
Your labs, health conditions and goals guide the choice. Tirzepatide is the usual first choice; semaglutide is preferred when protecting the heart is the priority.
Physician-led care · Limitless Performance Medicine
Meet with Joshua Hare, DO, at our Dalton clinic. Your history and baseline labs guide the care he designs and monitors.
Prefer a callback? Speak with Dr. Hare
1502 Dug Gap Road, Dalton, GA 30720In the same building as Interventional Pain Consultants · I-75, Exit 333 · Free parking
Plan your visit01 / Your care
Medication is one part of your care. Every program also addresses hormones, lean-mass protection and a plan for maintenance.
Your labs, health conditions and goals guide the choice. Tirzepatide is the usual first choice; semaglutide is preferred when protecting the heart is the priority.
Testosterone, thyroid and cortisol are screened and treated. Your hormone care and weight-loss care are coordinated in one chart.
Hormone therapyProtein, resistance training and creatine are part of the program, alongside medication and monitoring.
Read the lean-mass evidenceYour exit strategy is set at intake and revisited every six months. GLP-1s stay ongoing therapy unless you choose otherwise.
Monitoring and maintenanceWho this is for
FDA-labeled criteria for the obesity indication of Wegovy and Zepbound:
We deliberately decline to prescribe for patients with personal/family history of medullary thyroid carcinoma or MEN-2, active pancreatitis, severe gastroparesis, active eating disorders, pregnancy or planned pregnancy, BMI < 25 with no metabolic disease, or patients seeking short-term cosmetic loss without commitment to ongoing therapy and lifestyle architecture.
02 / Getting started
Every new patient first meets Dr. Hare in person at the Dalton clinic and has baseline labs before any medication is chosen.
Request a consultationAlready on a GLP-1 elsewhere?
Moving your care to Limitless
Meet in person at the Dalton clinic to review your history, goals, prior labs and contraindications.
CMP, A1c, fasting insulin, lipids, hormones (sex + thyroid + cortisol), hs-CRP, vitamin D, B12. Body composition (DEXA or InBody).
Drug selection, hormone correction, peptide adjuncts, training, protein and a supplement plan.
4-week tolerability check. 12-week labs and dose decision. 24-week full review.
We make the maintenance decision together: taper, hold or continue, based on your results, health conditions and goals.
03 / Medicines
The medicine is selected after your consultation and baseline labs.
Usual first choice
Zepbound · Mounjaro
Zepbound for weight management; Mounjaro for type 2 diabetes. Tirzepatide is also FDA-approved for obstructive sleep apnea in adults with obesity.
About tirzepatideWhen heart protection is the priority
Wegovy · Ozempic
Wegovy for weight management; Ozempic for type 2 diabetes. Semaglutide is approved for cardiovascular event reduction in patients with established CV disease.
About semaglutideLooking for a pill? The Wegovy pill (oral semaglutide) and Foundayo (orforglipron) are covered in the injection and pill FAQ.
Compare tirzepatide and semaglutideThese are the most-used adjuncts in the Limitless weight-loss program. Read the guide to care beyond GLP-1.
Related reading: The 2026 tesamorelin meta-analysis.
04 / Cost & insurance
You pay for the medicine through your pharmacy. The clinic's care is quoted at your consultation.
Cost, insurance and payment details05 / Here in Dalton
Your first consultation is in person. You'll find Limitless inside the same building as Interventional Pain Consultants.
Limitless Performance Medicine
1502 Dug Gap RoadIn the same building as Interventional Pain Consultants
I-75 at Exit 333 · Free parking
By appointment
25 minutes from Calhoun, 30 minutes from Chattanooga, 55 minutes from Rome and an hour from Cartersville.
Later on, many follow-up visits can be done by telehealth from anywhere in Georgia or Tennessee once you are an established patient.
Address, directions and contact detailsBefore you call
For questions about your care, request a callback or call 706-529-3698.
Take the 90-second assessmentYes, when they fit your labs and history. Both are FDA-approved and prescribed at Limitless: tirzepatide as Zepbound, semaglutide as Wegovy. Tirzepatide is the usual first choice; semaglutide is preferred when protecting the heart is the priority.
For tirzepatide and injectable semaglutide, yes — once weekly subcutaneous, similar to insulin in technique. We train you in clinic. Two GLP-1 pills are now FDA-approved for weight management: the Wegovy pill (oral semaglutide, December 2025) and Foundayo (orforglipron, April 2026). Foundayo produces significantly less weight loss than the injectables but needs no injection.
Yes, and many of our patients are. We coordinate everything in one chart. For women in perimenopause or menopause, the page on weight gain in perimenopause and menopause explains which option to pick on the request form. For men, the page on men's health in Dalton shows how testosterone, erectile and urinary care fit with weight care.
Your exit strategy is set at intake and revisited every six months, and GLP-1s stay ongoing therapy unless you choose otherwise.
Our GLP-1 candidate guide sets out the monitoring schedule, and its one-year step covers the maintenance dose decision, a taper-and-hold strategy and refining the exit plan. The same guide lists people who lost weight before and regained it, including after bariatric surgery, among the patients we readily prescribe for.
New-patient consultation is in person at our Dalton clinic. Subsequent visits and management can be telehealth across the state of Georgia. Patients regularly travel from Chattanooga, Knoxville, Atlanta, Birmingham, and Asheville for care.
If another clinician already prescribes your GLP-1, see moving your GLP-1 care to Limitless.
From the research library
Dr. Hare's daily protocol: Not medical advice. A working example.
Editorial note. This page describes the medical weight-loss program at Limitless Performance Medicine as of May 2026. Trial efficacy figures (Phase 3 means) do not predict any individual patient's response. Retatrutide is investigational and not FDA-approved. FDA status last reviewed November 5, 2026. Nothing on this page is a prescription or diagnosis. Decisions about weight-loss therapy require a physician evaluation, lab work, and ongoing monitoring. Black-box warnings, contraindications, and FDA labeling apply to all prescribed therapies and are reviewed at consultation.
Request a callback
Leave your name and number, and he will personally reach out within one business day.
Limitless / Dalton, GA
Your first visit is in person with Dr. Hare in Dalton, and baseline labs come before any medication is chosen.
Dr. Hare also founded Interventional Pain Consultants (IPC), which shares our building in Dalton. This number is IPC's main Dalton line.
Take the assessment · 90 sec